Driving improved outcomes
Often billed as the ‘silent killer’, liver disease has become more prevalent in recent years, with one in every five people now at risk1.
According to British Liver Trust, early liver screening could save £600m and thousands of lives2, however, current diagnostic methods such as liver biopsy procedures are increasingly being viewed as an expensive, uncomfortable and potentially risky. As an innovator of solutions, Siemens Healthineers is one of the first companies to provide a range of in vivo and in vitro diagnostic technologies for chronic liver disease patients.
These solutions are engineered to quickly and efficiently provide vital clinical information, working towards improving value, efficiency and patient care, with liver disease diagnostics offerings including:
- Screening of patients at risk in primary and secondary care settings
- Non-invasive tests enabling an improved patient experience
- Direct markers of liver fibrogenesis, which can be used in all forms of liver disease to assess the level of liver fibrosis
- Accurate and continuous staging of disease
- Prognostic information
Enhanced Liver Fibrosis (ELF™) test
The ELF test is a simple, routine blood test that allows you to assess the severity of liver fibrosis. Use of the test has been established in viral hepatitis, NAFLD and alcoholic patient groups and works as a more convenient method of diagnosis.
- Requires only a routine serum sample
- Consists of three serum biomarkers: HA, PIIINP, TIMP-1
- Easily requested along with other routine blood tests
From ADVIA Centaur® XP and ADVIA© Centaur XPT to the new Atellica IM® systems, Siemens Healthineers Laboratory Diagnostics offers fully automated immunoassay platforms and a comprehensive, disease-focused menu in excess of 100 tests, to deliver powerful productivity and efficiency, providing better medical information to clinicians.
To find out how iLFT pathways, Siemens Healthineers Aptio® Automation and CentraLink® Data Management Solutions have been used at NHS Tayside to improve diagnosis of liver disease and patient outcomes, read the case study.